SBRT for centrally localized NSCLC – What is too central?

PURPOSE: Current guidelines recommend stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer (NSCLC) in medically inoperable patients. There are excellent outcome and toxicity data for SBRT of peripheral lung tumors. However, the discussion on SBRT for centrally located tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Roesch, J., Panje, C., Sterzing, F., Mantel, F., Nestle, U., Andratschke, N., Guckenberger, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135810/
https://www.ncbi.nlm.nih.gov/pubmed/27912764
http://dx.doi.org/10.1186/s13014-016-0732-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135810/
https://www.ncbi.nlm.nih.gov/pubmed/27912764
http://dx.doi.org/10.1186/s13014-016-0732-5

Ejemplares similares